ISPOR - An Assessment of Factors associated with high costs among Patients With Multiple Sclerosis (Ms) Receiving Disease-Modifying Drug (Dmd) Therapy

Full Text

An Assessment of Factors associated with high costs among Patients With Multiple Sclerosis (Ms) Receiving Disease-Modifying Drug (Dmd) Therapy

Abstract

Authors

JC Locklear M Frean AL Phillips J Menzin

Back to Volume 18, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now